The latest closing stock price for Kymera Therapeutics as of July 30, 2025 is 44.07.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $325 today, roughly 0 times their original investment - a 5.79% compound annual growth rate over 5 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 20.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 19.45, which is 55.9% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 40.53.
An investor who bought $1,000 worth of Kymera Therapeutics stock at the IPO in 2020 would have $325 today, roughly 0 times their original investment - a 5.79% compound annual growth rate over 5 years.
The all-time high Kymera Therapeutics stock closing price was 87.83 on December 28, 2020.
The Kymera Therapeutics 52-week high stock price is 53.27, which is 20.9% above the current share price.
The Kymera Therapeutics 52-week low stock price is 19.45, which is 55.9% below the current share price.
The average Kymera Therapeutics stock price for the last 52 weeks is 40.53.